Chronic myeloid leukaemia: open trials in Canada

10 open trials have a site in Canada. Registry data; only the trial team decides who can take part.

NCT07354074
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Trial Treatment · Phase 2 · Novartis Pharmaceuticals
Edmonton · Montreal
Registry updated 2026-10-15
NCT04256317
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Trial Treatment · Phase 2/3 · Taiho Oncology, Inc.
Eastern Health - Health Sciences Centre, St. John's · Princess Margaret Cancer Centre, Toronto
Registry updated 2026-10-06
NCT04996875
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Trial Treatment · Phase 2 · Cogent Biosciences, Inc.
University of Alberta Hospital, Edmonton · St. Michael's Hospital, Unity Health Toronto, Toronto
Registry updated 2026-09-15
NCT06423911
Study of Olverembatinib (HQP1351) in Patients With CML-CP
Trial Treatment · Phase 3 · Ascentage Pharma Group Inc.
Toronto
Registry updated 2026-09-15
NCT05702645
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
Research · Children's Oncology Group
This trial only enrols participants with Down syndrome
Children's Hospital, London
Registry updated 2026-08-25
NCT04093570
A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)
Trial Treatment · Phase 2 · Taiho Oncology, Inc.
University of Alberta Hospital, Edmonton · QEII Health Sciences Centre, Nova Scotia · The Ottawa Hosptial, Ottawa · Princess Margaret Cancer Center, Toronto · Sunnybrook Health Sciences Centre, Toronto
Registry updated 2026-07-28
NCT04877522
Asciminib Roll-over Study
Trial Treatment · Phase 4 · Novartis Pharmaceuticals
Montreal
Registry updated 2026-07-06
NCT05304377
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
Trial Treatment · Phase 1 · Enliven Therapeutics
University Health Network UHN Princess Margaret Cancer Centre, Toronto
Registry updated 2026-04-01
NCT04260022
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
Trial Treatment · Phase 1 · Ascentage Pharma Group Inc.
Princess Margaret Cancer Centre, Toronto
Registry updated 2025-11-05
NCT02760238
Myeloproliferative Neoplasms (MPNs) Patient Registry
Research · University Health Network, Toronto
Princess Margaret Cancer Centre, Toronto
Registry updated 2024-08-27

All Chronic myeloid leukaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error